CDR1as is upregulated in CDDP-resistant NSCLC cells, whereas its overexpression enhances the stemness signatures (SOX2, OCT4, and Nanog) via the miR-641/HOXA9 axis and confers resistance to CDDP-sensitive NSCLC cells (191). Here, NANOG is linked to non-small cell lung carcinoma.